Outlook Therapeutics Stock Quote 41ON - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.308 52 Week Range 0.386

Market Cap

Previous Close

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

0.00

Shares Outstanding

260,257,517

Dividend Yield

PE Ratio

-5.21

Earnings Per Share (EPS)

-0.29

Revenue

Net Profit

-75.37M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.outlooktherapeutics.com

Headquarters

Dover, Delaware, USA

Founded

Outlook Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker 41ON. The last closing price for Outlook Therapeutics was -. Over the last year, Outlook Therapeutics shares have traded in a share price range of 0.308 € to 0.386 €.

Outlook Therapeutics currently has 260,257,517 shares outstanding. Outlook Therapeutics has a price to earnings ratio (PE ratio) of -5.21.

Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD First positive reimbursement...

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

Outlook Therapeutics® Announces UK MHRA Marketing Authorization of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD UK MHRA...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	0	0	0	0	0	DE
52	0.386	0.386	0.308	6114	0.35461254	DE
156	0.26	0.81	0.185	67056	0.35791761	DE
260	0.26	0.81	0.185	67056	0.35791761	DE

41ON - Frequently Asked Questions (FAQ)

What is the current Outlook Therapeutics share price?

The current share price of Outlook Therapeutics is 0.00 €

How many Outlook Therapeutics shares are in issue?

Outlook Therapeutics has 260,257,517 shares in issue

What is the 1 year trading range for Outlook Therapeutics share price?

Outlook Therapeutics has traded in the range of 0.308 € to 0.386 € during the past year

What is the PE ratio of Outlook Therapeutics?

The price to earnings ratio of Outlook Therapeutics is -5.21

What is the reporting currency for Outlook Therapeutics?

Outlook Therapeutics reports financial results in USD

What is the latest annual profit for Outlook Therapeutics?

The latest annual profit of Outlook Therapeutics is USD -75.37M

What is the registered address of Outlook Therapeutics?

The registered address for Outlook Therapeutics is 800 NORTH STATE STREET, SUITE 304, DOVER, DELAWARE, 19901

What is the Outlook Therapeutics website address?

The website address for Outlook Therapeutics is www.outlooktherapeutics.com

Which industry sector does Outlook Therapeutics operate in?

Outlook Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
P2WParrot	11.00 € (53.20%)	118.59k
0IU0Us Critical Metals Corp	0.053 € (42.47%)	100
CLIQCliq Digital AG	4.805 € (37.88%)	91.46k
601AAmmPower Corp	0.0196 € (36.11%)	225.11k
EVBDynamite Blockchain Corp	0.05 € (34.41%)	24.56k
9I0Pluto Ventures Inc	0.049 € (-57.02%)	17k
SL2Sleep Number Corp	7.50 € (-37.50%)	82
DW3Venture Global Inc	8.44 € (-36.06%)	1.34k
EUSKore Mining Ltd	0.015 € (-30.23%)	3k
OY9Orion Office REIT Inc	2.50 € (-30.21%)	10.57k
LHADeutsche Lufthansa AG	7.852 € (9.82%)	11.72M
D7GNel ASA	0.1718 € (-5.50%)	9.52M
E3BEutelsat Communications	6.25 € (-23.83%)	7.76M
TKAThyssenkrupp AG	9.69 € (7.07%)	4.66M
PF8European Lithium Limited	0.0252 € (-11.27%)	2.36M